Roche’s test, which measures the blood level of pTau181, a protein that builds up in the brain tissue of Alzheimer’s patients ...

GeneDx announces that the FDA has granted Breakthrough Device Designation for its whole genome and exome tests.

Scientists at UCSF have uncovered evidence that multiple sclerosis silently damages the brain years before diagnosis. By ...

The Fort St. John Hospital Foundation has purchased a body plethysmograph, a vital piece of equipment for the respiratory ...

The Galleri blood test by Grail can be given annually and looks for the DNA ‘fingerprint’ of more than 50 deadly cancers.

True Diagnostics, Inc. announced today that it has been awarded a Project Award through the Rapid Response Partnership Vehicle (RRPV) to advance the development of the VeriClear EbV MARV Rapid Antigen ...

During the COVID-19 pandemic, AI-assisted sequencing pipelines were instrumental in tracking SARS-CoV-2 variants, ...

A blood test that screens for more than 50 cancers is correct in 62% of cases where it thinks people may have the disease, a ...

Arrowhead Clinic – Duluth continues to address the critical need for immediate medical attention following auto accidents by ...

Clinical studies are essential to the future of healthcare. They allow researchers to refine new ideas, give patients a voice ...

The availability of a rule-in-rule-out test for Alzheimer’s disease in primary care settings is likely to drive efficiencies throughout the care continuum.

In an NHS trial British experts have discovered that the test correctly identified that more than a third of people thought ...